Skip to content
Brand AI

Actuate Therapeutics, Inc.

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2019

    Actuate Therapeutics completes $6.5 million Series B-3 financing

    Actuate Therapeutics announced it had raised an additional $6.5 million in a Series B-3 financing round led by Bios Partners, with Kairos Ventures, DEFTA Partners, and other existing investors participating. The company said it would use the proceeds to initiate a Phase 2 trial in myelofibrosis and expand its ongoing 1801 clinical trial.

    Source